摘要:
An ethylene-responsive transcription co-activator (MBF) acts on ethylene-responsive transcription factors (ERFs), which positively controls the expression of ethylene-responsive plant genes. A plant is transformed by the gene of the co-activator, and a promoter that may increase or decrease responsiveness to ethylene depending on its alignment. A method for controlling the responsiveness of plants to ethylene transforms a plant comprising an ERF-dependent gene, which positively control the expression of ethylene responsive genes of plants. This transcription co-activator gene is applied to control ethylene response of plants.
摘要:
The purpose of the present invention is to identify a transcription coactivator (transcriptional cofactor, MBF) in ethylene-responsive transcription factors (ERFs), to elucidate the mechanism of the action of MBF to ERF, which positively controls the expression of ethylene-responsive genes of plants, and furthermore, to provide a method for controlling the ethylene response of plants. An ethylene-responsive transcription coactivator (SEQ ID NO: 1 and 2) was identified. The transcription coactivator is demonstrated to be a transcription coactivator for ERF, which positively control the expression of ethylene-responsive genes of plants. This transcription coactivator gene can be applied to control ethylene response of plants.
摘要翻译:本发明的目的是鉴定乙烯应答转录因子(ERFs)中的转录共激活因子(转录辅因子,MBF),以阐明MBF对ERF的作用的机制,该功能正向控制乙烯应答基因的表达 的植物,此外,提供一种控制植物的乙烯应答的方法。 鉴定了乙烯应答转录共激活因子(SEQ ID NO:1和2)。 转录共激活因子被证明是ERF的转录共激活因子,其能正确控制植物乙烯应答基因的表达。 该转录共激活子基因可用于控制植物的乙烯应答。
摘要:
A method of producing a low-molecular weight peptide mixture, comprising the steps of dissolving a first protease in a buffer solution adjusted to an optimum pH for the protease ranging from pH 3 to 10, adding at least one first protein in a buffer solution having a pH of from 3 to 10 and a concentration of 10 to 60% by weight of the protein material and thoroughly mixing the solution, adding a solution of an ester of at least one amino acid pre-formed by esterification of the amino acid with an alcohol, the pH of said buffer solution being optimum for the incorporation of said amino acid in said starting protein in the presence of said first protease in a plastein reaction, reacting said ester of at least one amino acid with said starting protein in a plastein reaction in the mixed solution whereby said at least one amino acid is covalently incorporated into said starting protein to produce a plastein reaction solution containing a modified protein, hydrolyzing said modified protein using at least one second protease having a different specificity from said at least one first protease to produce a low-molecular weight peptide mixture having an amino acid content which has different proportions of amino acids than does said starting protein, and separating from the solution said low-molecular weight peptide mixture which comprises a major proportion of dipeptides and tripeptides and containing not more than 15% by weight of free amino acids and not more than 20% by weight of a high-molecular weight fraction of compounds having a molecular weight of not lower than 700 and removable by gel filtration. The said low-molecular weight peptide mixture is readily absorbable and a useful nutrient.
摘要:
A low-molecular weight peptide composition mainly based on dipeptides and tripeptides is produced by dispersing protein raw material from any suitable source in water at a concentration of 5 to 20 w/v %, adjusting the pH of the dispersion to 1 to 4 with an acid, adding at least two acid proteases to the dispersion, and permitting enzymatic proteolysis to take place for a desired period of time at a suitable temperature while supressing the formation of free amino acids. Also provided is a nutrient agent comprising the thus produced low-molecular weight peptide composition mainly based on dipeptides and tripeptides wherein the contents of free amino acids and those peptides having a molecular weight of at least 700 are individually 20% by weight or less. The nutrient agent is useful in medical treatment.